PMC:7252008 / 34-173 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":12,"end":16},"obj":"Gene"},{"id":"4","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"5","span":{"begin":44,"end":53},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"Gene:3569"},{"id":"A4","pred":"tao:has_database_id","subj":"4","obj":"MESH:C000657245"},{"id":"A5","pred":"tao:has_database_id","subj":"5","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"lts of anti-IL 6 therapy in severe COVID-19 infection\n\nDear Editor,\nWe thank Cunningham et al. [1] and Ruscitti et al. [2] for their commen"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"T2","span":{"begin":44,"end":53},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"lts of anti-IL 6 therapy in severe COVID-19 infection\n\nDear Editor,\nWe thank Cunningham et al. [1] and Ruscitti et al. [2] for their commen"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":12,"end":14},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A3","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"lts of anti-IL 6 therapy in severe COVID-19 infection\n\nDear Editor,\nWe thank Cunningham et al. [1] and Ruscitti et al. [2] for their commen"}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":55,"end":67},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"lts of anti-IL 6 therapy in severe COVID-19 infection\n\nDear Editor,\nWe thank Cunningham et al. [1] and Ruscitti et al. [2] for their commen"}